Weight-loss drugs such as Wegovy and Ozempic may become the new frontline warriors in treating and preventing drug and alcohol addiction, a large new study shows. The research, published Wednesday in ...

Researchers are investigating whether GLP-1 drugs could be used to treat addiction disorders, following patient reports of reduced cravings.

A major new study out of the Department of Veterans Affairs’ St. Louis Health Care System found that GLP-1 medications, the class of drugs that includes Ozempic, Wegovy, Mounjaro and Zepbound, are ...

Al-Aly is a physician and researcher at Washington University in St. Louis and chief of research at the VA Saint Louis Health Care System. At a dinner party recently, someone poured my friend a glass ...

Prescription weight loss drugs have been lauded as the miracle drug for treating diabetes and obesity, but new research suggests that these drugs, known as glucagon-like peptide-1 (GLP-1) receptor ...

There is new evidence that drugs like Ozempic can reduce a person's risk of addiction. A large study found that people who started taking GLP-1 drugs for weight loss or diabetes were less likely to ...

Evidence continues to mount suggesting that GLP-1 drugs may help people cut back on cigarettes, drinking and opioid use. Subscribe to read this story ad-free Get unlimited access to ad-free articles ...

There's growing evidence that GLP-1 drugs can treat more than diabetes and obesity. “It was a surprise to people. Here's an anti-obesity drug that could be useful for addiction, which is thought of as ...

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.